Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06216756 · ClinicalTrials.gov registry record · NA
Evaluating Cryopreserved Osteochondral Allograft Cores for the Treatment of Osteochondral Lesions in the Knee
A NA study of Osteochondral Defect, sponsored by AlloSource.
- Recruiting
- Registry status
- NA
- Development phase
- 68
- Enrollment target
- 6
- Study locations
NCT06216756 is a NA study of Osteochondral Defect that is actively recruiting participants, run by AlloSource. The registered enrollment target is 68 participants. The trial reports 6 study locations across 4 states.
The verdict
NCT06216756, a NA study of Osteochondral Defect, is actively recruiting participants, sponsored by AlloSource.
- RECRUITING
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
- 6
- Study locations
Study Summary
The primary objective of this study is to obtain evidence of the effectiveness of Cryopreserved Osteochondral Allograft Core in the treatment of osteochondral lesions on the femoral condyle.
Conditions Studied
Interventions
- PROCEDURE osteochondral transplant on the femoral condyle
Study Locations (6)
California
- Cedars-Sinai Kerlan Jobe Institute - Los Angeles
- Stanford Medicine-Orthopaedics and Sports Medicine in Redwood City - Redwood City
- University of California San Francisco - San Francisco
Arizona
- Banner- University Medical Center- Phoenix Orthopedic and Sports Medicine Institute - Phoenix
Illinois
- Rush Copley Medical Center - Aurora
Kentucky
- University of Kentucky Research Foundation - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2024-12-01 |
| Est. Completion | 2031-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06216756
The ClinicalTrials.gov registry entry for NCT06216756 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AlloSource, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Osteochondral Defect appearing as the primary indexed condition, and to 1 intervention - of which osteochondral transplant on the femoral condyle is the first listed.
NCT06216756 reports 6 study locations spanning 4 distinct geographic areas - top geographies include California, Arizona, Illinois.
Frequently Asked Questions
What is clinical trial NCT06216756 about?
NCT06216756 is a clinical study titled "Evaluating Cryopreserved Osteochondral Allograft Cores for the Treatment of Osteochondral Lesions in the Knee". The primary objective of this study is to obtain evidence of the effectiveness of Cryopreserved Osteochondral Allograft Core in the treatment of osteochondral lesions on the femoral condyle.
What is the current status of trial NCT06216756?
This trial is currently recruiting. It is a NA study. The enrollment target is 68 participants. The study started on 2024-12-01. Estimated completion is 2031-03.
What conditions does trial NCT06216756 study?
This clinical trial studies the following conditions: Osteochondral Defect.
What interventions are being tested in trial NCT06216756?
The interventions under investigation include: osteochondral transplant on the femoral condyle (PROCEDURE).
Who is sponsoring clinical trial NCT06216756?
This trial is sponsored by AlloSource, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06216756 being conducted?
This trial has 6 study locations across Arizona, California, Illinois, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteochondral Defect
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.